Pagsiat, Czymon Brian L.
HRN: 20-55-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/15/2022
06/21/2022
PO
4.5 Ml
TID
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes